Softbank Group Corp Recursion Pharmaceuticals, Inc. Transaction History
Softbank Group Corp
- $22.6 Billion
- Q4 2024
A detailed history of Softbank Group Corp transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Softbank Group Corp holds 14,667,491 shares of RXRX stock, worth $154 Million. This represents 0.44% of its overall portfolio holdings.
Number of Shares
14,667,491Holding current value
$154 Million% of portfolio
0.44%Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
337Shares Held
284MCall Options Held
2.83MPut Options Held
3.64M-
Vanguard Group Inc Valley Forge, PA34MShares$358 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.3MShares$341 Million1.91% of portfolio
-
Baillie Gifford & CO24.9MShares$262 Million0.13% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$182 Million0.0% of portfolio
-
State Street Corp Boston, MA12.6MShares$132 Million0.0% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.9B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...